Evidence map›Paper›PMID 41620132›Full record

ArticleUrology2026

Reply to Editorial Comment on "Laboratory Abnormalities Associated With the Use of Preventive Pharmacological Therapy for Urinary Stone Disease".

Matthew S Lee, Raul Garcia Maya, Autumn Valicevic, Mary K Oerline, Sanjeevkumar Patel, John M Hollingsworth, Ryan S Hsi, Vahakn B Shahinian

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matthew S LeeDepartment of Urology, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: matthew.lee@osumc.edu.
Raul Garcia MayaDepartment of Nephrology, University of Michigan, Department of Veterans Affairs, Ann Arbor, MI.
Autumn ValicevicDepartment of Nephrology, University of Michigan, Department of Veterans Affairs, Ann Arbor, MI.
Mary K OerlineDepartment of Nephrology, University of Michigan, Department of Veterans Affairs, Ann Arbor, MI.
Sanjeevkumar PatelDepartment of Nephrology, University of Michigan, Department of Veterans Affairs, Ann Arbor, MI.
John M HollingsworthDepartment of Urology, University of Florida, Gainesville, FL.
Ryan S HsiDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN; Department of Urology, University of California, Irvine, Orange, CA.
Vahakn B ShahinianDepartment of Nephrology, University of Michigan, Department of Veterans Affairs, Ann Arbor, MI; Department of Urology, University of Michigan, Ann Arbor, MI.

Funding

Real-world effectiveness of preventive pharmacological therapy for patients with kidney stonesR01DK121709 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLLINGSWORTH, JOHN MALCOLM, SHAHINIAN, VAHAKN B · 2020 to 2024
$3.0M
NIDDK NIH HHS R01 DK121709
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41620132
PMCPMC13532565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.